MSF/Médecins Sans Frontières [to 29 July 2017]
DRC: Doctors Without Borders Vaccinates More than One Million Children Against Measles
July 28, 2017
As measles sweeps across Democratic Republic of Congo (DRC), more than one million children have been vaccinated against the deadly disease during a nine-month campaign by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).
MSF Sounds Alarm Over High Numbers of People Dying from AIDS in Africa
July 25, 2017
Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.
CEPI – Coalition for Epidemic Preparedness Innovations [to 29 July 2017]
08 July 2017
CEPI welcomes global leadership shown by government of Norway
Media release, Oslo– CEPI welcomes the vital contribution of additional funding from the government of Norway, which today announced it is increasing its original investment in CEPI by $70m. The government of Norway is a founding investor in CEPI, which will create new vaccines against epidemic threats through an innovative partnership between public, private, philanthropic and civil organizations.
Together with the governments of Germany and Japan, the Bill & Melinda Gates Foundation and Wellcome, the founding investors contributed a total of $540m to launch CEPI in January 2017. CEPI’s mission is to outsmart epidemics by developing safe and effective vaccines against known infectious diseases that can be deployed rapidly to contain outbreaks, before they become global health emergencies…
NIH [to 29 July 2017]
July 20, 2017
Immune system may mount an attack in Parkinson’s disease
July 27, 2017 — NIH-funded study suggests role for specific immune cells in brain disease.
Discovery documentary First in Human gives an up-close look at how advances in medicine are made at the NIH Clinical Center
July 26, 2017 — Three-part series airing in August portrays the hopes and setbacks of patients, doctors, and nurses seeking cures.
In adolescents, oral Truvada and vaginal ring for HIV prevention are safe, acceptable
July 25, 2017 — NIH-funded clinical trials are first of their kind to include younger adolescent girls.
NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers
July 24, 2017 — Nationwide trial to explore targeted therapies for children and adolescents with solid tumors.
Drug interaction concerns may negatively affect HIV treatment adherence among transgender women
July 24, 2017 — Participants in NIH-supported study apprehensive about combining HIV medications and hormones.
Experimental HIV vaccine regimen is well-tolerated, elicits immune responses
July 24, 2017 — Results from early-stage NIH-funded trial support further development of candidate vaccines.
Child living with HIV maintains remission without drugs since 2008
July 24, 2017 — Child treated in infancy as part of NIH-funded study.
PATH [to 29 July 2017]
Announcement | July 26, 2017
Kenya County Governor Signs Landmark Maternal Child Health and Family Planning Act
The law is the first in the country to allocate county-level resources to support access to critical health services for the most vulnerable mothers, newborns, and children
Kakamega County Governor H.E. Wycliffe Oparanya of Western Kenya signed the Kakamega County Maternal Child Health and Family Planning Bill 2017 into law, guaranteeing pregnant women living on less than one US dollar a day additional support to access essential antenatal and postnatal care for themselves and their babies. PATH Kenya advocates, UNICEF, and other partners played a key role in guiding the overarching strategy for the bill, drafting core language, and securing critical buy-in from high-level leaders and civil society members…
UNAIDS [to 29 July 2017]
UNAIDS welcomes the launch of the End AIDS Coalition at the 9th International AIDS Conference on HIV Science in Paris
PARIS/GENEVA, 25 July 2017—UNAIDS has welcomed the launch of the End AIDS Coalition (EAC) during the 9th International AIDS Conference on HIV Science taking place in Paris, France. The EAC brings together a strong collaboration of leading AIDS experts, scientists, clinicians, policy-makers, faith leaders, business leaders and activists determined to end the AIDS epidemic as a public health threat by 2030.
The EAC aims to amplify efforts to end the AIDS epidemic by strengthening linkages across research, resources and implementation, by encouraging the aggregation and analysis of data from the global AIDS response to identify barriers and encourage efficiencies and by inspiring a movement to mobilize and engage the next generation of young leaders in the response to HIV…
FDA [to 29 July 2017]
What’s New for Biologics
Influenza Virus Vaccine for the 2017-2018 Season
European Medicines Agency [to 29 July 2017]
Concept paper on development and lifecycle of personalised medicines and companion diagnostics
Public consultation to end on 31 October 2017 …
EU report: more evidence on link between antibiotic use and antibiotic resistance
The European Food Safety Authority, the European Medicines Agency and the European Centre for Disease Prevention and Control are concerned about the impact of use of antibiotics on the increase in antibiotic-resistant bacteria. …
Reducing off-label use of antimicrobials in veterinary medicine to reduce risk of resistance
EMA invites comments on a draft reflection paper by 31 January 2018
GHIT Fund [to 29 July 2017]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical ·
New investment opportunity for Hit-to-lead Platform
New investment opportunity for Product Development Platform
New investment opportunity for Target Research Platform in Partnership with Wellcome Trust
Wellcome Trust [to 29 July 2017]
News / Published: 26 July 2017
Mike Ferguson is new Deputy Chair of Governors
Professor Mike Ferguson will become Deputy Chair of our Board of Governors in January 2018. He is taking over from Professor Dame Kay Davies.
Mike, who is Regius Professor of Life Sciences at the University of Dundee, has been on the Board of Governors since January 2012.
Opinion / Published: 26 July 2017
Let’s transform the way research is translated into health benefits
Stephen Caddick, Wellcome’s Director of Innovation, says building a UK environment where research findings are translated into treatments and products is a challenge – but one we must meet.
It’s good to see the launch of Transforming UK translation [PDF 99KB], a set of commitments from the leading science and engineering organisations, including Wellcome, to transform UK research translation.
PhRMA [to 29 July 2017]
July 27, 2017
Biopharmaceutical industry policies aim to increase access to clinical trial data
The biopharmaceutical industry has been at the forefront of initiatives to improve access to clinical trial data.
July 25, 2017
Finding cures for incurable diseases
74 percent of the medicines in the pipeline have the potential to be first-in-class therapies.